Alamo (ALG) Stock

ALG, GEF and HTCMY have been added to the Zacks Rank #5 (Strong Sell) List on December 9, 2024.

AUBURN HILLS, Mich., Nov. 19, 2024 /PRNewswire/ --  All-new Dodge Charger Daytona, the next generation of American muscle and the first all-electric vehicle from the Dodge brand, achieves highest residual value in J.D.

AMRK, ANIK and ALG have been added to the Zacks Rank #5 (Strong Sell) List on November 11, 2024.

Alamo Group Inc (NYSE:ALG ) Q3 2024 Earnings Conference Call November 1, 2024 10:00 AM ET Company Participants Edward Rizzuti - Executive Vice President, General Counsel and Secretary Jeff Leonard - President and Chief Executive Officer Agnes Kamps - Executive Vice President, Chief Financial Officer, and Treasurer Conference Call Participants Mike Shlisky - D.A. Davidson Chris Moore - CJS Securities Mig Dobre - Baird Greg Burns - Sidoti & Company Operator Good day, and welcome to the Alamo Group Inc. Third Quarter 2024 Conference Call.

SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced positive topline results from the Phase 2a HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction associated steatohepatitis (MASH) subjects.

SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Company will share the topline results from the Phase 2a HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction associated steatohepatitis (MASH) subjects on Thursday, September 19, 2024 prior to the market open. Following the announcement, the Company will host a conference call and webcast at 8:30am ET/5:30am PT.

Alamo Group is a well-managed, stable company with strong fundamentals, making it an attractive investment for conservative investors. Alamo Group is efficiently allocating capital with a consistently higher ROIC than its competitors, but it lacks a significant competitive moat. Key growth catalysts include increasing infrastructure spending, superior capital allocation, and resolution of temporary setbacks, though the cyclical nature of the Vegetation Management Division poses a risk.

Alamo Group Inc (NYSE:ALG ) Q2 2024 Results Conference Call August 1, 2024 10:00 AM ET Company Participants Edward Rizzuti - Executive Vice President, General Counsel and Secretary Jeff Leonard - President and Chief Executive Officer Agnes Kamps - Executive Vice President, Chief Financial Officer, and Treasurer Conference Call Participants Chris Moore - CJS Securities Mike Shlisky - D.A. Davidson Mig Dobre - Baird Greg Burns - Sidoti & Company Operator Good day, and welcome to the Alamo Group Inc. Second Quarter 2024 Conference Call.

SAN ANTONIO, July 09, 2024 (GLOBE NEWSWIRE) -- Big Sky Medical, a leading healthcare real estate investment firm, today announced the acquisition of Sunset at Treeline, a cutting-edge medical outpatient building in San Antonio's prestigious Alamo Heights neighborhood. The off-market transaction secures a strategically located property adjacent to the CHRISTUS Santa Rosa Alamo Heights campus, with high visibility along Highway 281.